menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Desvenlafaxine: The Newest Antidepressant

close
Desvenlafaxine:  The Newest Antidepressant
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do you need to know about this medicine? Host Dr. Leslie Lundt welcomes Dr. Philip Ninan, vice president for Neuroscience Global Medical Affairs at Wyeth Pharmaceuticals to discuss the ins and outs of desvenlafaxine.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do you need to know about this medicine? Host Dr. Leslie Lundt welcomes Dr. Philip Ninan, vice president for Neuroscience Global Medical Affairs at Wyeth Pharmaceuticals to discuss the ins and outs of desvenlafaxine.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/4/20